← Back to catalogue

Thermo Scientific QMS Everolimus Reagents, Calibrators and Controls

FDA 510(k)FDA UDIEUDAMED

Class II (US FDA 510(k))

510(k) K100144Ref 0373878

by Microgenics Corporation

Identity

Trade Name
QMS Everolimus Immunoassay Control Set FDA UDI
Generic Name
Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent FDA UDI
Device Name
QMS Everolimus Control EUDAMED
Model / Reference
0373878 EUDAMEDFDA UDI

Identifiers

Primary DI / UDI-DI
00884883004597 EUDAMEDFDA UDI
Basic UDI-DI
B-00884883004597 EUDAMED
510(k) Number
K100144 FDA 510(k)
FDA Product Code
OUF FDA 510(k)
LAS FDA UDI
EMDN Code
W0102080606 EVEROLIMUS EUDAMED
GMDN Term
Rapamycin (sirolimus) therapeutic drug monitoring IVD, reagent FDA UDI

Classification

Device Class
Class IVD General EUDAMED
Class II FDA 510(k)
Class I FDA UDI
Legislation / Framework
21 CFR Part 862.3840 FDA 510(k)
Regulation Number
862.3840 FDA 510(k)
862.3280 FDA UDI
Market of Registration
Germany EUDAMED
Advisory Committee
Clinical Toxicology FDA 510(k)
FDA Decision
SESE Substantially Equivalent FDA 510(k)
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

EUDAMEDFDA UDI

Single Use

Yes

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Human Tissues

Yes

EUDAMED

Animal Tissues

No

EUDAMED

Microbial Substances

Yes

EUDAMED

Reagent

Yes

EUDAMED

Self Testing

No

EUDAMED

Near-Patient Testing

No

EUDAMED

Professional Testing

Yes

EUDAMED

Companion Diagnostics

No

EUDAMED

Surgical Instrument

No

EUDAMED

Prescription Use

No

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

No

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

Yes

FDA UDI

Lot / Batch Number

Yes

FDA UDI

Serial Number

No

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

This device is an Everolimus Immunoassay reagent set, designed for quantitative measurement of everolimus in biological samples. It includes calibrators, controls, and reagents for use in immunoassay testing, enabling accurate detection and monitoring of the drug’s concentration in clinical toxicology applications.

The QMS Everolimus Reagents, Calibrators and Controls are supplied as a kit for in vitro diagnostic use, intended for single-use only. They are regulated under the FDA’s 510(k) pathway (K100144) and the In Vitro Diagnostic Device Directive (IVDD), with a classification of Class II. Storage and handling must comply with manufacturer guidelines to maintain sterility and performance.

Frequently asked questions

What clinical area is this immunoassay kit primarily used for, and why is it important in that field?

This kit is designed for clinical toxicology, specifically for measuring everolimus levels in biological samples. It’s critical in this field because everolimus is an immunosuppressive drug used post-transplant, and precise monitoring helps avoid toxicity (e.g., organ damage) or underdosing (e.g., graft rejection). The quantitative assay ensures accurate drug concentration tracking, supporting patient safety and treatment efficacy.

Is this kit reusable, or is it meant for single-use only? How does that affect its storage and handling?

The kit is intended for single-use only, as explicitly stated in the manufacturer’s instructions. This design minimizes contamination risks and ensures consistent, reliable results per batch. Storage must follow the manufacturer’s guidelines to preserve sterility and performance—typically refrigerated or frozen until use, with strict adherence to expiration dates to prevent degradation of reagents, calibrators, or controls.

What regulatory pathways does this device follow, and how does that classification impact its use in clinical settings?

The kit is regulated under the FDA’s 510(k) pathway (K100144) and the In Vitro Diagnostic Device Directive (IVDD), with a Class II classification. This classification indicates moderate risk, requiring validation of performance (e.g., accuracy, precision) but not the stringent scrutiny of Class III devices. Clinically, this means it’s subject to routine quality control checks and compliance with manufacturer protocols to ensure reliable everolimus measurement for patient monitoring.

How are the calibrators and controls included in this kit used, and why are they essential for accurate testing?

The kit includes calibrators (to define the concentration scale for everolimus) and controls (to verify assay performance across batches). Calibrators ensure the assay’s linearity and accuracy by mapping measured signals to known drug concentrations, while controls (e.g., low/high-level) confirm reproducibility and detect assay drift or errors. Without them, results could be unreliable, leading to misdiagnosis of drug levels or treatment failures.

What should clinicians or labs consider when ordering this kit, beyond just the device itself?

Clinicians or labs should verify compatibility with their assay platform (e.g., automated immunoassay systems) and confirm the kit’s expiration date upon receipt, as reagents degrade over time. Additionally, they must ensure proper storage conditions (e.g., refrigeration) are maintained to preserve sterility and functionality. Training staff on handling single-use components and interpreting results within the kit’s specified limits is also critical for clinical validity.

This description and any FAQs above were generated automatically from registry data and have not been verified by the manufacturer or by deviCERTS. Always check the official registry entry and the manufacturer's instructions for use before relying on them. Sources consulted: Thermo Fisher Scientific - DE, DE - Thermo Fisher Scientific, Thermo Scientific - Fisher Sci, Thermo Fisher Scientific – Wikipedia, Thermo Fisher Scientific - Wikipedia

Authorization Coverage (2 countries)

Regulatory Authorizations

European Union Active

IVDD

United States Active

FDA_510K

Is this your device? Claim it to add documentation and request validation.

Manufacturer

FDA Applicant
Microgenics Corp.

Sources (3)

  • FDA 510(k) K100144 24 fields · synced Sep 18, 2026
  • FDA UDI bced6050-95ed-4d09-9468-0bd6547e80ae 32 fields · synced May 30, 2026
  • EUDAMED 3280ea14-fd20-414b-bfc1-c1af1f53a357 61 fields · synced Jul 9, 2026